Legal News

A Mississippi pharmacist has agreed to forfeit $2 million he earned through an online scheme that distributed painkillers to customers who had not received medical consultations.

If you're waffling on the idea of taking out professional liability insurance, read this and think again.

A month after New York ordered Target, Walmart, Walgreens, and GNC to stop selling herbal supplements that routinely did not contain the ingredients advertised, one of the giant retailers has been hit with a class action lawsuit.

A California pharmacist has filed a class-action lawsuit against Walmart, accusing the retail giant of cheating pharmacists out of work breaks and overtime pay.

With only 15% of New York's healthcare providers ready for e-Rx of controlled substances, New York legislators have agreed to push back the March 27 deadline by one year.

A group of 55 pharmacies located mainly in Pennsylvania has turned to the courts to resolve reimbursement differences with Catamaran.

If the draft of the legislation was aimed at misleading the voters, as one of the drafters appears to have admitted, such conduct could constitute gross negligence.

Paper is about to become history in one of the largest prescription drug markets in the country.

A pharmacist's failure to counsel can result in severe, life-changing consequences for the patient.

Among four New York retail chains, only 21% of store-brand supplements tested contained the plant material named on their labels.

FDA is seeking to learn how these Wallcur products, which are not sterile and should not be injected in humans or animals, entered the supply chain.

Agency will use guidance in 2015 to address “key policy issues.”

Agency kicks medical product safety-monitoring into a higher gear.

A judge has reinstated the pharmacy license of a former Rhode Island state senator who mistakenly gave morphine to an infant and a toddler.

Until now, DEA has interpreted the Controlled Substances Act in its own special way. Now two senators launch legislation geared to the needs of everyone else.

In 36 states, a pharmacist's apology will not be construed as an admission of liability. In the other states, it's a different story.

The documents seek to clarify the regulatory process for compounders of sterile human drugs.

Pharmacies that accept copayment coupons should take immediate steps to address the issues raised by OIG.

Patients should decide how a pharmacy can best communicate with patients. And they can use a very American way to make their feelings known.

CVS Health’s pharmacy benefits management company will pay $6 million to settle federal charges it failed to reimburse Medicaid for prescription costs also covered by private plans, according to the U.S. Department of Justice.

A federal appeals court upheld an Alameda County, California ordinance that requires drug manufacturers to pay disposal costs for unused medications.

The West Virginia Board of Pharmacy has created a list of suspected “doctor shoppers” and given it to law enforcement officials, according to a report in the Charleston Gazette.

Federal agents Thursday arrested the former supervising pharmacist of New England Compounding Center in Massachusetts, which in 2012 provided tainted drugs that led to a fungal meningitis outbreak that killed 64 people and sickened more than 700.

Healthcare providers who share HIPAA-protected health information with certain service providers must update their written agreements by September 22, 2014.

Physicians are responsible for prescribing and dispensing. Pharmacists have a corresponding responsibility to fill those prescriptions appropriately.

Pharmacists dealing with Rxs for controlled substances have their lists of red flags and greens flags. Are they now showing the white flag, as well?

Title II of the DQSA is the Drug Supply Chain Security Act. As of January 1, 2015, new changes and mandates will move all members of the supply chain closer to becoming mandatory oversight partners with FDA.

A New York City pharmacist was recently charged with stealing 193,000 painkiller pills worth an estimated $5.6 million on the black market.

Rite Aid recently agreed to pay $498,250 to settle charges that some of its California pharmacists frequently did not provide patient consultations required by law.

The Supplemental Bulletin expands upon previous guidance, focusing particularly on disease funds and legitimate copay waivers for prescribed medications.